Go to the list of all blogs
Jimmy Landsman's Avatar
published in Blogs
Nov 18, 2026
TickeronGET DAILY SIGNALS
Innovator U.S. Equity Buffer ETF – November (BNOV): A Defined Outcome Strategy

Innovator U.S. Equity Buffer ETF – November (BNOV): A Defined Outcome Strategy

Key Takeaways

  • BNOV is an exchange-traded fund (ETF) from Innovator ETFs that seeks to match the price return of the SPDR S&P 500 ETF Trust up to a predetermined cap while buffering the first 9% of losses over a one-year outcome period.
  • The fund is a defined outcome (or "buffer") ETF, a category designed for investors who want equity exposure with a built-in downside cushion.
  • BNOV launched on October 31, 2019, is listed on Cboe BZX, and carries a net expense ratio of 0.79%.
  • Its portfolio is built primarily from FLEX Options on the SPDR S&P 500 ETF Trust rather than a basket of individual stocks.
  • The ETF is non-diversified and its returns are tied to the large-cap U.S. equity market, with meaningful sector exposure to technology and financials.

Getting to Know BNOV

Innovator U.S. Equity Buffer ETF – November (BNOV) is a "defined outcome" exchange-traded fund (ETF) that offers investors a way to participate in U.S. large-cap stock market gains up to a cap, while providing a degree of protection against the first portion of market declines. ETFs are pooled investment vehicles that trade on an exchange like individual stocks. Rather than simply tracking an index, BNOV uses a structured options strategy to define the range of outcomes an investor can expect over a specific one-year period, which is why it appeals to investors seeking a more predictable risk-and-return profile than a conventional index fund. I also checked this using Tickeron’s AI Screener to see how the fund compares to others in the category.

How BNOV Is Structured

BNOV is issued by Innovator ETFs, a firm that pioneered the U.S. defined-outcome ETF category. The fund launched on October 31, 2019, and is listed on Cboe BZX. Its investment objective is to provide returns that match the price return of the SPDR S&P 500 ETF Trust (the "Underlying ETF"), up to an upside cap, while buffering investors against the first 9% of losses in that Underlying ETF over a designated outcome period. For the November series, each outcome period runs for roughly one year, typically from November 1 to October 31 of the following year.

The fund is passively managed in the sense that its strategy is rules-based and resets each year, but it differs from a traditional index ETF because it does not simply hold the underlying stocks. Instead, BNOV holds FLEX Options—customizable exchange-listed options contracts—on the SPDR S&P 500 ETF Trust. These options create the buffer and cap structure that defines the fund's outcomes. The fund is classified as non-diversified and carries a net expense ratio of 0.79%, which covers management and operational costs.

Portfolio Holdings and Asset Allocation

Because BNOV uses options rather than buying stocks directly, its portfolio holdings look different from a typical equity ETF. The overwhelming majority of the fund's assets are held in FLEX Options on the SPDR S&P 500 ETF Trust, typically accounting for nearly all of the portfolio's net assets, with a small residual position in cash and cash equivalents. This structure means the fund's underlying economic exposure mirrors the S&P 500 Index, so its sector exposure broadly reflects the large-cap U.S. market—historically led by technology, followed by financial services, communication services, healthcare, and consumer discretionary.

The investment strategy is rebalanced on a fixed schedule. At the start of each outcome period, the fund sets a new upside cap based on prevailing market conditions and option pricing, and re-establishes the 9% buffer. Investors who enter the fund mid-period should note that the remaining cap and buffer may differ from the amounts set at the beginning of the outcome period.

Why Investors Follow BNOV

BNOV attracts investors who want to stay invested in U.S. equities but are uncomfortable with the full downside risk of the market. The 9% buffer cushions the first portion of losses over the one-year period, which can help reduce portfolio volatility and provide peace of mind during market downturns. At the same time, the upside cap means the fund gives up some potential gains in exchange for that protection—a trade-off central to the defined-outcome concept.

The fund can serve as a core equity holding for conservative investors or as a complement to a broader portfolio, offering diversification by smoothing out the extremes of market performance. Its one-year reset schedule also allows investors to plan around a known risk-and-return profile, which is uncommon among traditional index funds. From what I see, this predictable structure is one of the main reasons the fund continues to draw attention.

Key Risks and Important Considerations

  • Upside cap: BNOV's returns are limited by its cap, so investors will not fully participate in strong market rallies above that threshold.
  • Buffer limitations: The 9% buffer protects only against the first portion of losses; declines beyond 9% will be reflected in the fund's value on a roughly one-for-one basis.
  • Outcome period timing: The cap and buffer reset annually, and investors who buy or sell mid-period may receive different protection and upside than those who hold for the full period.
  • Counterparty and options risk: The FLEX Options are guaranteed for settlement by the Options Clearing Corporation (OCC), but the fund bears risk related to the performance and settlement of those contracts.
  • Market and concentration risk: As a non-diversified fund tied to the S&P 500, BNOV is exposed to broad U.S. equity market risk, including sector exposure concentrated in technology and other large-cap names.
  • Costs: The 0.79% expense ratio is higher than many traditional index ETFs and can reduce net returns over time.

How Tickeron’s AI Screener Supports My Research

In my analysis of funds like this, I often turn to Tickeron’s AI Screener to quickly compare defined-outcome ETFs against peers using technical indicators, volatility metrics, and customizable filters. It helps me surface ideas that align with specific risk parameters and build more informed watchlists without sifting through endless data manually. This has become a practical step in refining my research process for structured products.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: BNOV

Contributor

My name is Jimmy, and I’m a financial analyst focused on identifying compelling opportunities across the ETF market. Each day, I analyze hundreds of ETFs to uncover potential trading and investment opportunities using a broad range of market factors. For short-term trading, I rely heavily on technical analysis, including price channels, momentum indicators, support and resistance levels, trend patterns, and other market signals. At the same time, I dedicate significant attention to evaluating ETFs from a long-term investment perspective. My objective is to build a well-balanced ETF portfolio that combines core investment holdings with more tactical and speculative positions. The goal is to create a portfolio that can participate effectively in market rallies while also remaining resilient during periods of volatility and market corrections.


BNOV in downward trend: price dove below 50-day moving average on October 30, 2026

BNOV moved below its 50-day moving average on October 30, 2026 date and that indicates a change from an upward trend to a downward trend. In 29 of 35 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are 83%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 29, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BNOV as a result. In 44 of 76 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 58%.

The Moving Average Convergence Divergence Histogram (MACD) for BNOV turned negative on October 15, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In 22 of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at 48%.

The 10-day moving average for BNOV crossed bearishly below the 50-day moving average on November 02, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 10 of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 77%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BNOV declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 65%.

The Aroon Indicator for BNOV entered a downward trend on November 17, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.

Following a +1.89% 3-day Advance, the price is estimated to grow further. Considering data from situations where BNOV advanced for three days, in 261 of 385 cases, the price rose further within the following month. The odds of a continued upward trend are 68%.

BNOV may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Notable companies

The most notable companies in this group are Apple (NASDAQ:AAPL), NVIDIA Corp (NASDAQ:NVDA), Microsoft Corp (NASDAQ:MSFT), Alphabet (NASDAQ:GOOGL), Alphabet (NASDAQ:GOOG), Amazon.com (NASDAQ:AMZN), Meta Platforms (NASDAQ:META), Tesla (NASDAQ:TSLA), Broadcom Inc. (NASDAQ:AVGO), Eli Lilly & Co (NYSE:LLY).

Industry description

The investment seeks to provide investors with returns that match the price return of the SPDR® S&P 500® ETF Trust. The fund has adopted a policy pursuant to Rule 35d-1 under the 1940 Act to invest, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in investments that provide exposure to the SPDR® S&P 500® ETF Trust (the “Underlying ETF”). It is non-diversified.

Market Cap

The average market capitalization across the Innovator U.S. Equity Buffer ETF - November (BNOV) ETF is 140.46B. The market cap for tickers in the group ranges from 7.11B to 5T. AAPL holds the highest valuation in this group at 5T. The lowest valued company is MOS at 7.11B.

High and low price notable news

The average weekly price growth across all stocks in the Innovator U.S. Equity Buffer ETF - November (BNOV) ETF was 8%. For the same ETF, the average monthly price growth was 45%, and the average quarterly price growth was 322%. CHRW experienced the highest price growth at 7%, while MRNA experienced the biggest fall at -18%.

Volume

The average weekly volume growth across all stocks in the Innovator U.S. Equity Buffer ETF - November (BNOV) ETF was 9%. For the same stocks of the ETF, the average monthly volume growth was -7% and the average quarterly volume growth was -16%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 71
P/E Growth Rating: 52
Price Growth Rating: 41
SMR Rating: 50
Profit Risk Rating: 58
Seasonality Score: 15 (-100 ... +100)
AI Screener 3
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
Interact to see
Advertisement
UNH dropped -7.80% to $359.29 from Tuesday's $389.68 close, extending a two-session decline to roughly -13% and touching its lowest level in about seven weeks; the move occurred during regular market hours. The selloff accelerated on the CMS "CRUSH" proposal unveiled Nov. 16, which would extrapolate Medicare Advantage risk-adjustment audit findings from samples across entire contracts back to payment year 2018 and drop the fee-for-service adjuster; CMS estimates roughly $9 billion in industry clawbacks per payment year, and UnitedHealth, the largest MA insurer, has not sized its exposure.
SAP's U.S. shares fell from Monday's close of $233.83 to $221.99 by late Tuesday morning in New York, a -5.06% decline recorded during regular trading hours. The company-specific trigger was the announced exit of Chief Customer Officer Thomas Saueressig, an executive board member since 2019, who will leave at the end of March 2027 to become CEO of IONOS; the disclosure came before the U.S. open.
Different growth engines: MRVL is riding accelerating AI data-center demand for custom chips and networking, while QCOM remains heavily tied to a soft smartphone market. Momentum contrast: Marvell's data-center revenue guidance has strengthened, whereas Qualcomm's near-term outlook has been pressured by memory-supply constraints and shrinking handset volumes.
TMC fell from Monday's $2.11 close to $1.96 by 10:10 a.m. ET, a -7.11% decline that occurred entirely in the regular session after an early premarket gain faded. No verified news or fundamental catalyst found for the drop; the move is likely technical, extending the post-Q3 unwind that followed NOAA pushing its certification decision to mid-December, with the stock averaging a 4.0% daily swing and logging 11 sessions of 7%-or-larger moves in the last 60.
IonQ slid from Monday's close of $26.45 to $24.73 on Tuesday, a -6.50% move that unfolded during regular trading hours after modest premarket gains faded. The decline was sector-driven rather than company-specific: quantum and AI-adjacent speculative names extended a multi-session liquidation ahead of Nvidia's quarterly report, with unease over Nvidia's abrupt CEO transition keeping risk appetite weak.